TNFRSF9 Inhibits Pancreatic Cancer Progression by Regulating PAX6-mediated Cell Proliferation, Migration, and Apoptosis
The study suggests that TNFRSF9 may hold promise as a therapeutic target in PDA management, given its potential to inhibit tumor growth and modulate cell behavior.
Authors
- Zhaofeng Gao
- Fei Chen (ORCID: https://orcid.org/0000-0002-7600-1945)
- Xiaorong Liu (ORCID: https://orcid.org/0000-0002-8912-5066)
- Minjie Chen (ORCID: https://orcid.org/0000-0002-6430-552X)
- Lingyu Hu (ORCID: https://orcid.org/0000-0002-5698-7700)
- Xiaoping Li (ORCID: https://orcid.org/0000-0002-4803-4539)
Institutions
- Jiaxing University (CN)
- First Hospital of Jiaxing (CN)
Publication Details
- Journal
- Pancreas
- Published
- 2025-04-21
- DOI
- https://doi.org/10.1097/mpa.0000000000002497
- Citations
- 1
- Primary Topic
- interferon and immune responses
- Type
- article
- Field-Weighted Citation Impact
- 0.80